Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer
出版年份 2018 全文链接
标题
Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer
作者
关键词
-
出版物
CANCER SCIENCE
Volume 109, Issue 2, Pages 363-372
出版商
Wiley
发表日期
2017-11-30
DOI
10.1111/cas.13459
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Androgen Receptor Function and Androgen Receptor–Targeted Therapies in Breast Cancer
- (2017) Miho Kono et al. JAMA Oncology
- PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer
- (2016) Weiwei Zhang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer
- (2016) R Mimoto et al. ONCOGENE
- Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma
- (2016) Xiubing Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer
- (2016) Haiyan Yan et al. PLoS One
- Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma
- (2015) Yuchan Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer
- (2015) Xiaoling Gu et al. MEDICAL ONCOLOGY
- Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis
- (2015) Xing Guo et al. NATURE CELL BIOLOGY
- PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion
- (2015) Lei Yang et al. PLoS One
- DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma
- (2015) Noriko Yamaguchi et al. TUMOR BIOLOGY
- Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy
- (2015) Shunichiro Nomura et al. BMC Urology
- Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer
- (2014) Yasuko Enomoto et al. TUMOR BIOLOGY
- DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail
- (2013) Rei Mimoto et al. CANCER LETTERS
- Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
- (2012) H Miyagaki et al. BRITISH JOURNAL OF CANCER
- DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells
- (2012) Naoe Taira et al. JOURNAL OF CLINICAL INVESTIGATION
- Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
- (2011) Mohammad H Forouzanfar et al. LANCET
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- The MAPPER2 Database: a multi-genome catalog of putative transcription factor binding sites
- (2011) A. Riva NUCLEIC ACIDS RESEARCH
- A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility
- (2011) W K C Leung et al. ONCOGENE
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- The cell death machinery governed by the p53 tumor suppressor in response to DNA damage
- (2009) Kiyotsugu Yoshida et al. CANCER SCIENCE
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
- (2009) Yu Chen et al. LANCET ONCOLOGY
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started